Cadila slumps after Citi downgrade

Tags: Companies
Shares of Cadila Healthcare fall around 10 percent after Citigroup downgrades them to "sell" from "buy".

Citi says Cadila's valuations "have moved well ahead of fundamentals," despite gradual recovery in the sector and improving US business.

Prefers Aurobindo Pharma and Glenmark Pharmaceuticals in midcaps among drugmakers.

EDITORIAL OF THE DAY

  • We need a plan to manage the world’s largest population

    Is demographic dividend going to be a nightmare for India?

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Sandeep Bamzai

Freedom Files : Creating a communal cleave

The Nawab of Bhopal Sir Hafiz Hamidullah Khan, saboteur ...

Susan Visvanathan

Landed in trouble

The British always required get away places. Shimla is the ...

Zehra Naqvi

Mindful meditation in everyday life

Amid the vast multitude of tasks and huge amounts of ...